Loading Events

« All Events

  • This event has passed.

National workshop: From diagnosis of cancer to diagnosis of Lynch syndrome

November 10 2021 @ 1:00 PM - 2:00 PM

|Recurring Event (See all)

One event on November 29 2021 at 1:00 PM

 

Workshops focused around the roles and responsibilities of local cancer MDT members in the Lynch syndrome testing pathway.

 

Lynch syndrome (LS) is an inherited condition caused by pathogenic variants in DNA genes which result in an increased risk of colorectal, endometrial, and other cancers.
  • Increases risk of developing bowel cancer to up to 80%
  • Previously called hereditary non-polyposis colorectal cancer (HNPCC).
LS affects approximately 1 in 300-1 in 400 people, with 200,000-300,000 people likely to have this condition in the UK. It is estimated that only 5% of people with LS have been diagnosed with this condition.
NICE guidelines recommend universal testing for LS in people with colorectal (CRC) [DG27] and endometrial cancer [DG42].

 

Workshop leads:
  • Kevin Monahan, Consultant Gastroenterologist at St Mark’s Hospital and Co-Chair of the national NHS GMS Lynch Syndrome Oversight Group
  • Adam Shaw, Consultant Geneticist at Guy’s and St Thomas’ and Co-Chair of the national NHS GMS Lynch Syndrome Oversight Group

 

All cancer MDT members are welcome. Please register via the Eventbrite page (https://national-workshop-lynch-cancer-mdts.eventbrite.co.uk/) to one of the two virtual workshops.

Venue

Online
United Kingdom

Organisers

NHS South East Genomic Medicine Service Alliance
NHS North Thames Genomic Medicine Service Alliance

Critical incident affecting genomics tests from Viapath

The issues with our IT systems have now been resolved  and our laboratory is processing all tests and referrals sent to us.

Please be aware that as normal services resume you may experience some delays to receiving results and the reports may look different.

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.